About

Here you will find summaries of all the latest publications on lupus, focusing on those covering treatments, recommendations and other topics that may influence clinical practice.

Latest Updates

All ▼
Publication thumbnail: Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 Trial (SLE-BRAVE-I)

Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 Trial (SLE-BRAVE-I)

Publication thumbnail: 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Publication thumbnail: Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics (SLICC) Cohort using Multistate Modelling

Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics (SLICC) Cohort using Multistate Modelling

Publication thumbnail: Lupus Low Disease Activity State Attainment in the Phase 3 TULIP Trials of Anifrolumab in Active Systemic Lupus Erythematosus

Lupus Low Disease Activity State Attainment in the Phase 3 TULIP Trials of Anifrolumab in Active Systemic Lupus Erythematosus

Publication thumbnail: Relationship Between the EULAR/ACR Classification Criteria and Organ Damage in Systemic Lupus Erythematosus

Relationship Between the EULAR/ACR Classification Criteria and Organ Damage in Systemic Lupus Erythematosus

Aurinia Announces European Approval of LUPKYNIS (voclosporin)

Jourde-Chiche et al, 2022

van Vollenhoven et al, 2022

Dörner et al, 2022

Literature Highlights, July 2022

Furie et al, 2021

Literature Highlights, October 2021

Iolascon et al, 2021

Isenberg et al, 2021